NCT06629337View on ClinicalTrials.gov

Effect of Aerobic Exercise with Blood Flow Restriction on Post-exercise Hypotension in Young Adults: the Role of Histamine Receptors

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Prehypertension (elevated Blood Pressure) or Hypertension
Interventions
GENETIC

H1 receptor blockade: 540 mg (Allegra), H2 receptor blockade: 40 mg (Pepcid AC)

Subjects ingested fexofenadine (540 mg, tablet) at least 50 minutes before and famotidine (40 mg, tablet) 1 hour 50 minutes before the onset of each protocol because these dose of oral fexofenadine and famotidine reaches its peak concentration at around 1 h and 2 h, respectively

Trial Locations (1)

92504

California Baptist University, Riverside

All Listed Sponsors
lead

California Baptist University

OTHER

NCT06629337 - Effect of Aerobic Exercise with Blood Flow Restriction on Post-exercise Hypotension in Young Adults: the Role of Histamine Receptors | Biotech Hunter | Biotech Hunter